Werbung
Werbung

HAE

HAE logo

Haemonetics Corporation

82.03
USD
Gesponsert
-2.01
-2.39%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

82.05

+0.02
+0.02%

HAE Ergebnisberichte

Positives Überraschungsverhältnis

HAE übertreffen die 33 der letzten 39Schätzungen.

85%

Nächster Bericht

Datum des nächsten Berichts
04. Feb. 2026
Estimate for Q3 26 (Revenue/ EPS)
$334.95M
/
$1.26
Implizierte Änderung von Q2 26 (Revenue/ EPS)
+2.33%
/
-0.79%
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-3.90%
/
+5.88%

Haemonetics Corporation earnings per share and revenue

On 06. Nov. 2025, HAE reported earnings of 1.27 USD per share (EPS) for Q2 26, beating the estimate of 1.12 USD, resulting in a 13.26% surprise. Revenue reached 327.31 million, compared to an expected 314.51 million, with a 4.07% difference. The market reacted with a +32.31% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 12 analysts forecast an EPS of 1.26 USD, with revenue projected to reach 334.95 million USD, implying an decrease of -0.79% EPS, and increase of 2.33% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
For Q2 2026, Haemonetics Corporation reported EPS of $1.27, beating estimates by 13.26%, and revenue of $327.31M, 4.07% above expectations.
The stock price moved up 32.31%, changed from $50.72 before the earnings release to $67.11 the day after.
The next earning report is scheduled for 04. Feb. 2026.
Based on 12 analysts, Haemonetics Corporation is expected to report EPS of $1.26 and revenue of $334.95M for Q3 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung